Crossmark

Malignant Pleural Mesothelioma: an Update for Pulmonologists

Crossref DOI link: https://doi.org/10.1007/s13665-019-0224-9

Published Online: 2019-05-02

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sidhu, Calvinjit

Louw, Amber

Brims, Fraser

Creaney, Jenette

Lee, Y. C. Gary
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

First Online: 2 May 2019

Compliance with Ethical Standards

:

: Rocket Med Plc and CareFusion/BD provided drainage kits without charge for participants of the AMPLE-2 trial and OPTIMUM trial respectively. Prof Lee led the former and is a co-investigator for the latter. The AMPLE-2 trial has also received a unrestricted educational grant from Rocket Med Plc. Prof Lee has served on the advisory board of CareFusion/BD. Prof Lee and Creaney are investigators of a clinical trial which AstraZeneca provided the investigation drug without charge.

: This article does not contain any studies with human or animal subjects performed by any of the authors.